FMC Corporation Navigates Challenging Market Conditions, Focuses on Strengthening Balance Sheet

FMC Corporation, a global agricultural sciences company, has faced a difficult operating environment in 2026 as growers carefully manage their purchases in response to strained margins driven by low crop prices and elevated input costs. The company’s revenue and profitability have declined, leading FMC to take strategic actions to optimize its cost structure and strengthen its balance sheet.

Financial Performance Overview In the second quarter of 2026, FMC’s revenue decreased 17% to $867.1 million compared to the same period in 2025. Excluding the impact of the company’s India business, which is being divested, revenue declined 20% primarily due to lower sales volumes and pricing pressure. Gross margin decreased 16% to $342.1 million, with the gross margin percentage remaining flat at around 39%.

For the first half of 2026, revenue declined 12% to $1.63 billion, again excluding the India business. Volumes were down 5% and pricing declined 17% due to competitive market pressures, partially offset by favorable foreign currency impacts. Gross margin decreased 19% to $588.7 million, with the gross margin percentage declining to 36%.

The company’s net loss for the second quarter was $186.3 million, compared to net income of $67.8 million in the prior year period. This was largely driven by a significant increase in restructuring and other charges related to the company’s cost optimization initiatives. Adjusted after-tax earnings from continuing operations, which exclude special charges, decreased 62% to $33.1 million.

For the first half of 2026, the net loss was $467.5 million, compared to net income of $52.2 million in the prior year. The loss was driven by the restructuring charges as well as a $124.7 million increase in the company’s valuation allowance for deferred tax assets. Adjusted after-tax earnings from continuing operations decreased 96% to $4.2 million.

Strengthening the Balance Sheet To address the challenging market conditions and strengthen its financial position, FMC has taken several strategic actions:

• In June 2026, the company entered into a co-exclusive agreement with Corteva, Inc. to develop and commercialize the rimisoxafen herbicide product. FMC received an initial prepayment of $200 million, which was used to pay down debt.

• Also in June 2026, FMC announced plans to sell its global R&D headquarters property in Newark, Delaware for approximately $114 million, subject to closing conditions. The company intends to lease back the facilities it actively operates while applying the proceeds to debt reduction.

• In May 2026, FMC signed a definitive agreement to sell its commercial business in India to Crystal Crop Protection Limited for $252 million. The company plans to use these proceeds to further pay down debt.

• In June 2026, FMC completed a $1.2 billion private offering of 8.000% Senior Secured Notes due 2031. The proceeds were used to redeem $500 million of existing senior notes and repay outstanding borrowings under the company’s revolving credit facility.

• Additionally, in June 2026, FMC announced that the Tessenderlo Group, a Belgian industrial group, will make a strategic minority equity investment of approximately $400 million in the company. This transaction is expected to close in the coming months, subject to regulatory approvals.

These various transactions are expected to enable FMC to pay down a significant portion of its debt in 2026, strengthening the company’s balance sheet and financial flexibility.

Operational Priorities and Outlook Looking ahead, FMC’s key priorities for 2026 include:

1. Strengthening the balance sheet through debt reduction using the proceeds from the rimisoxafen licensing agreement, the sale of the India business and the Newark, Delaware property, as well as the Tessenderlo Group investment.

2. Improving the competitiveness of the company’s legacy core portfolio of crop protection products.

3. Managing the transition as key patents expire on the company’s Rynaxypyr® insecticide active ingredient.

4. Supporting the growth of new active ingredients such as Isoflex® active, fluindapyr, Dodhylex™ active and rimisoxafen.

However, FMC expects the challenging operating environment to continue, with further pressure on pricing due to competitive market dynamics for core portfolio products and lower Rynaxypyr® active pricing. The company plans to maintain its focus on reducing costs, which are expected to be lower for the full year 2026.

Strengths and Weaknesses FMC’s key strengths include its diverse portfolio of crop protection products, its strong research and development capabilities, and its global footprint. The company has a history of innovation and has been successful in bringing new active ingredients to market. FMC’s geographic diversification also helps mitigate risks in any single region.

However, the company’s reliance on a few key products, such as Rynaxypyr®, leaves it vulnerable to patent expirations and increased competition. The recent challenges in the India market and the need to optimize the company’s cost structure and manufacturing footprint also highlight areas of weakness.

Additionally, FMC’s high debt levels have limited its financial flexibility, necessitating the strategic actions taken to strengthen the balance sheet. The company’s ability to successfully execute its debt reduction plan and navigate the current market pressures will be crucial to its future performance.

Outlook and Conclusion FMC faces a difficult operating environment in 2026, with continued pressure on pricing and volumes due to competitive dynamics and strained grower economics. However, the company’s strategic actions to optimize its cost structure, divest non-core assets, and strengthen its balance sheet should position it for improved financial performance in the future.

The successful execution of FMC’s debt reduction plan, the integration of new active ingredients into the product portfolio, and the company’s ability to maintain its competitive edge will be key factors in determining its long-term success. Investors will be closely watching FMC’s progress in these areas as the company works to navigate the current challenges and position itself for growth in the years ahead.